Amos Adler

7.6k total citations
140 papers, 3.2k citations indexed

About

Amos Adler is a scholar working on Epidemiology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, Amos Adler has authored 140 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Epidemiology, 58 papers in Molecular Medicine and 55 papers in Infectious Diseases. Recurrent topics in Amos Adler's work include Antibiotic Resistance in Bacteria (58 papers), Enterobacteriaceae and Cronobacter Research (22 papers) and Bacterial Identification and Susceptibility Testing (19 papers). Amos Adler is often cited by papers focused on Antibiotic Resistance in Bacteria (58 papers), Enterobacteriaceae and Cronobacter Research (22 papers) and Bacterial Identification and Susceptibility Testing (19 papers). Amos Adler collaborates with scholars based in Israel, United States and France. Amos Adler's co-authors include Yehuda Carmeli, A. Lerner, Shiri Navon‐Venezia, Elizabeth Temkin, Mitchell J. Schwaber, Ester Solter, Ronen Ben‐Ami, Itzhak Levy, Zmira Samra and Efrat Khabra and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Blood.

In The Last Decade

Amos Adler

136 papers receiving 3.1k citations

Peers

Countries citing papers authored by Amos Adler

Since Specialization

Citations

This map shows the geographic impact of Amos Adler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amos Adler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amos Adler more than expected).

Fields of papers citing papers by Amos Adler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amos Adler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amos Adler. The network helps show where Amos Adler may publish in the future.

Co-authorship network of co-authors of Amos Adler

This figure shows the co-authorship network connecting the top 25 collaborators of Amos Adler. A scholar is included among the top collaborators of Amos Adler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amos Adler. Amos Adler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	WarA, a remote homolog of NpmA and KamB from Nocardia wallacei, confers broad spectrum aminoglycoside resistance in Nocardia and Mycobacteria 2024 ·International Journal of Antimicrobial Agents ·(unknown), (unknown), Amos Adler, David Burstein, Daniel Barkan	4
2	The prevalence of antimicrobial drug resistance of non-typhoidal Salmonella in human infections in sub-Saharan Africa: a systematic review and meta-analysis 2024 ·Expert Review of Anti-infective Therapy ·(unknown), (unknown), Amos Adler, (unknown), Eric S. Donkor, Dani Cohen, Khitam Muhsen	5
3	Early signaling of bacteremia in patients who present to the department of emergency medicine with relatively low C-reactive protein (CRP) concentrations 2023 ·Clinica Chimica Acta ·(unknown), Tal Levinson, (unknown), Amos Adler, Ilana Goldiner, (unknown), Ori Rogowski, (unknown), David Zeltser, Itzhak Shapira, Shani Shenhar‐Tsarfaty, Shlomo Berliner, Asaf Wasserman	2
4	Early Antibiotic Deescalation and Discontinuation in Patients with Febrile Neutropenia after Cellular Therapy: A Single-Center Prospective Unblinded Randomized Trial 2023 ·Transplantation and Cellular Therapy ·Ron Ram, Odelia Amit, Amos Adler, Yael Bar‐On, Ofrat Beyar‐Katz, Irit Avivi, David Shasha, Ronen Ben‐Ami	6
5	Mpox proctitis as a likely predisposing factor for chlamydial perihepatitis in a male patient 2023 ·Sexually Transmitted Infections ·Shir Azrielant, (unknown), (unknown), Israel Nissan, Amos Adler, Michal Dekel	0
6	Humoral and Cellular Immune Responses of People Living With Human Immunodeficiency Virus After 3 Doses of Messenger RNA BNT162b2 Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine: A Prospective Cohort Study 2023 ·Open Forum Infectious Diseases ·(unknown), David Hagin, Tal Freund, Tamar Halperin, Amos Adler, (unknown), (unknown), (unknown), Inbar Levi, (unknown), (unknown), Tomer Ziv‐Baran, Dan Turner	3
7	A Shigella flexneri 2a synthetic glycan-based vaccine induces a long-lasting immune response in adults 2023 ·npj Vaccines ·Shiri Meron-Sudai, (unknown), Amos Adler, Anya Bialik, Sophy Goren, (unknown), (unknown), Laurence A. Mulard, Armelle Phalipon, Dani Cohen	7
8	Clinical and molecular features of NDM-producing Acinetobacter baumannii in a multicenter study in Israel 2023 ·Annals of Clinical Microbiology and Antimicrobials ·Amos Adler, Hiren Ghosh, Andrea M. Gross, (unknown), (unknown), Marc V. Assous, Yuval Geffen, (unknown), Yonit Wiener‐Well, (unknown), Hajo Grundmann, Sandra Reuter	5
9	Nosocomial transmission of MPOX virus to health care workers –an emerging occupational hazard: A case report and review of the literature 2023 ·American Journal of Infection Control ·(unknown), (unknown), Oryan Henig, (unknown), Ora Halutz, (unknown), (unknown), Michal Yakubovsky, Amos Adler, Ronen Ben‐Ami, Eli Sprecher, (unknown)	16
10	Clinical features and outcomes of bacteremic and non-bacteremic Campylobacteriosis: a case–control study 2022 ·Infection ·(unknown), Amos Adler, (unknown), Yael Paran, (unknown), David Shasha, Ronen Ben‐Ami	1
11	Prognostic value of neutrophil-to-lymphocyte ratio in COVID-19 compared with Influenza and respiratory syncytial virus infection 2021 ·Scientific Reports ·(unknown), (unknown), Jacob N. Ablin, Alexis Mitelpunkt, Ahuva Weiss‐Meilik, Amos Adler, Guy Choshen, (unknown)	61
12	Institutional Burden of Carbapenemase-Producing Enterobacterales: The Effect of Changes in Surveillance Culture Methodology 2020 ·Microbial Drug Resistance ·(unknown), Haim Ben‐Zvi, (unknown), Yuval Geffen, Amos Adler	3
13	Disseminated “Haemophilus quentini” infection in a patient with multiple myeloma — a case report and review of the literature 2019 ·Diagnostic Microbiology and Infectious Disease ·Regev Cohen, Talya Finn, (unknown), (unknown), Svetlana Paikin, Amos Adler, Yuval Geffen, Assaf Rokney, M. Ron	3
14	Risk factors for recurrent Clostridium difficile infection in a tertiary hospital in Israel 2018 ·European Journal of Clinical Microbiology & Infectious Diseases ·Wasef Na’amnih, Amos Adler, (unknown), Dani Cohen, Yehuda Carmeli	10
15	Does Acinetobacter baumannii Serve as a Source for bla _NDM Dissemination into Enterobacteriaceae in Hospitalized Patients? 2017 ·Microbial Drug Resistance ·Amos Adler, (unknown), Ziv Lifshitz, Yehuda Carmeli	7
16	Comparative performance study of six commercial molecular assays for rapid detection of toxigenic Clostridium difficile 2017 ·Clinical Microbiology and Infection ·Yossi Paitan, (unknown), Amos Adler	16
17	Dissemination of thebla_KPCgene by clonal spread and horizontal gene transfer: comparative study of incidence and molecular mechanisms 2016 ·Journal of Antimicrobial Chemotherapy ·Amos Adler, Efrat Khabra, Svetlana Paikin, Yehuda Carmeli	32
18	Prevalence, Risk Factors, and Transmission Dynamics of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae: a National Survey of Cattle Farms in Israel in 2013 2015 ·Journal of Clinical Microbiology ·Amos Adler, (unknown), Noga Fallach, (unknown), Omar Hussein, Shlomo E. Blum, Eyal Klement, Mitchell J. Schwaber, Yehuda Carmeli	23
19	Gastrointestinal colonization by KPC-producing Klebsiella pneumoniae following hospital discharge: duration of carriage and risk factors for persistent carriage 2012 ·Clinical Microbiology and Infection ·Noa Feldman, Amos Adler, Noa Molshatzki, Shiri Navon‐Venezia, Efrat Khabra, Dani Cohen, Yehuda Carmeli	104
20	Carbapenem-resistant Klebsiella pneumoniae endocarditis in a young adult 2009 ·International Journal of Infectious Diseases ·Shmuel Benenson, Shiri Navon‐Venezia, Yehuda Carmeli, Amos Adler, Jacob Strahilevitz, Allon E. Moses, Colin Block	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact